Clinical Trials Logo

Clinical Trial Summary

Investigation of the efficacy of Acceptance and Commitment Therapy (ACT) for the psychological treatment of problematic chemsex. As a pilot study, the intervention will be tested in a small group.


Clinical Trial Description

After being informed about the study, all patients giving written informed consent will be assessed to determine eligibility for study entry. Patients who meet eligibility requirements will receive psychological intervention consisting in an 8-session individual on line-delivered ACT-based treatment. The participants will be assessed through self-report instruments before and after treatment and at 3 months follow-up. The pilot study will not include a control group. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06408545
Study type Interventional
Source Universidad Europea de Madrid
Contact Francisco M Montesinos, Ph.D.
Phone +34647413773
Email francisco.montesinos@universidadeuropea.es
Status Recruiting
Phase N/A
Start date March 1, 2024
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Completed NCT00467558 - Double-Blind Naltrexone in Compulsive Sexual Behavior Phase 2
Not yet recruiting NCT06406296 - Effectiveness of ACT for Problematic Chemsex N/A
Enrolling by invitation NCT04634175 - Mind-body Intervention for Compulsive Sexual Behavior Disorder N/A
Completed NCT05572372 - Effects of an ACT-based Psychological Treatment in Patients With Hypersexuality N/A
Completed NCT02300051 - Intervention Study for Individuals With Compulsive Sexual Behavior N/A
Completed NCT03495414 - Neurobiological Underpinnings to Hypersexual Disorder